Haemophilus Influenzae (Hib) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants
Conditions: Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b Infection; Poliomyelitis; Hepatitis BInterventions: Biological: DTaP-IPV-Hep B-PRP~T combined vaccine; Biological: DTaP-IPV//PRP~T and Hepatitis B vaccineSponsor: Sanofi Pasteur, a Sanofi CompanyRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
Condition: Respiratory DisordersInterventions: Biological: NTHI vaccine GSK2838500A (formulation 1); Biological: NTHI vaccine GSK2838501A (formulation 2); Biological: NTHI vaccine GSK2838502A (formulation 3); Biological: NTHI vaccine GSK2838503A (formulation 4); Biological: NTHI vaccine GSK2838504A (formulation 5); Biological: NTHI vaccine GSK2838505A (formulation 6); Biological: NTHI vaccine GSK2838508A (formulation 7); Biological: NTHI vaccine GSK2838509A (formulation 8); Drug: Placebo comparatorSponsor: GlaxoSmithKlineCompleted - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2012 Category: Research Source Type: clinical trials

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis; Meningococcal Infection; Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Serotype b (Hib)Interventions: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate; Biological: Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed; Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b ConjugateSponsor: Sanofi Pasteur, a Sanofi CompanyActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2012 Category: Research Source Type: clinical trials

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
Conditions: Acellular Pertussis; Tetanus; Diphtheria; Haemophilus Influenzae Type bInterventions: Biological: Infanrix+Hib™; Biological: Poliorix™Sponsor: GlaxoSmithKlineCompleted - verified July 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2011 Category: Research Source Type: clinical trials